195 related articles for article (PubMed ID: 30946325)
1. Risk of Parkinson disease in Sjögren syndrome administered ineffective immunosuppressant therapies: A nationwide population-based study.
Ju UH; Liu FC; Lin CS; Huang WY; Lin TY; Shen CH; Chou YC; Lin CL; Lin KT; Kao CH; Chen CH; Yang TY
Medicine (Baltimore); 2019 Apr; 98(14):e14984. PubMed ID: 30946325
[TBL] [Abstract][Full Text] [Related]
2. Higher risk of Parkinson disease in patients with primary Sjögren's syndrome.
Hsu HC; Hou TY; Lin TM; Chang YS; Chen WS; Kuo PI; Lin YC; Chang CC; Chen JH
Clin Rheumatol; 2020 Oct; 39(10):2999-3007. PubMed ID: 32240432
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune rheumatic diseases and the risk of Parkinson disease: a nationwide population-based cohort study in Taiwan.
Chang CC; Lin TM; Chang YS; Chen WS; Sheu JJ; Chen YH; Chen JH
Ann Med; 2018 Feb; 50(1):83-90. PubMed ID: 29224375
[TBL] [Abstract][Full Text] [Related]
4. Hydroxychloroquine was associated with reduced risk of new-onset diabetes mellitus in patients with Sjögren syndrome.
Chen TH; Lai TY; Wang YH; Chiou JY; Hung YM; Wei JC
QJM; 2019 Oct; 112(10):757-762. PubMed ID: 31218368
[TBL] [Abstract][Full Text] [Related]
5. Sjögren's syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline treatment.
Komai K; Shiozawa K; Tanaka Y; Yoshihara R; Tanaka C; Sakai H; Yamane T; Murata M; Tsumiyama K; Hashiramoto A; Shiozawa S
Mod Rheumatol; 2009; 19(4):416-9. PubMed ID: 19452244
[TBL] [Abstract][Full Text] [Related]
6. Primary Sjogren's syndrome and the risk of acute pancreatitis: a nationwide cohort study.
Chang CC; Chang YS; Wang SH; Lin SY; Chen YH; Chen JH
BMJ Open; 2017 Aug; 7(8):e014807. PubMed ID: 28801391
[TBL] [Abstract][Full Text] [Related]
7. Risk of Chronic Obstructive Pulmonary Disease in Female Adults With Primary Sjögren Syndrome: A Nationwide Population-Based Cohort Study.
Shen TC; Wu BR; Chen HJ; Lin CL; Wei CC; Chen CH; Tu CY; Hsia TC; Shih CM; Hsu WH; Sung FC; Kao CH
Medicine (Baltimore); 2016 Mar; 95(10):e3066. PubMed ID: 26962839
[TBL] [Abstract][Full Text] [Related]
8. Use of muscarinic agonists in the treatment of Sjögren's syndrome.
Fox RI; Konttinen Y; Fisher A
Clin Immunol; 2001 Dec; 101(3):249-63. PubMed ID: 11726216
[TBL] [Abstract][Full Text] [Related]
9. Risk of dementia among patients with Sjogren's syndrome: A nationwide population-based cohort study in Taiwan.
Chen HH; Perng WT; Chiou JY; Wang YH; Huang JY; Wei JC
Semin Arthritis Rheum; 2019 Apr; 48(5):895-899. PubMed ID: 30075989
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the discontinuation rates and side-effect profiles of pilocarpine and cevimeline for xerostomia in primary Sjögren's syndrome.
Noaiseh G; Baker JF; Vivino FB
Clin Exp Rheumatol; 2014; 32(4):575-7. PubMed ID: 25065774
[TBL] [Abstract][Full Text] [Related]
11. Approaches to the treatment of Sjögren's syndrome.
Fox RI; Michelson P
J Rheumatol Suppl; 2000 Dec; 61():15-21. PubMed ID: 11128699
[TBL] [Abstract][Full Text] [Related]
12. Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.
Fox RI; Dixon R; Guarrasi V; Krubel S
Lupus; 1996 Jun; 5 Suppl 1():S31-6. PubMed ID: 8803908
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic CD4+ lymphocytopenia and Sjogren syndrome.
Wladis EJ; Kapila R; Chu DS
Arch Ophthalmol; 2005 Jul; 123(7):1012. PubMed ID: 16009850
[No Abstract] [Full Text] [Related]
14. Association between Periodontal Disease and Subsequent Sjögren's Syndrome: A Nationwide Population-Based Cohort Study.
Lin CY; Tseng CF; Liu JM; Chuang HC; Lei WT; Liu LY; Yu YC; Hsu RJ
Int J Environ Res Public Health; 2019 Mar; 16(5):. PubMed ID: 30832451
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the Detection of Subclinical Retinal Involvement in Systemic Lupus Erythematosus and Sjögren Syndrome: A Potential Association with Therapies.
Conigliaro P; Triggianese P; Draghessi G; Canofari C; Aloe G; Chimenti MS; Valeri C; Nucci C; Perricone R; Cesareo M
Int Arch Allergy Immunol; 2018; 177(1):45-56. PubMed ID: 29902805
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Sjögren's syndrome-associated dry eye an evidence-based review.
Akpek EK; Lindsley KB; Adyanthaya RS; Swamy R; Baer AN; McDonnell PJ
Ophthalmology; 2011 Jul; 118(7):1242-52. PubMed ID: 21459453
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjögren's syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study.
Leung KC; McMillan AS; Wong MC; Leung WK; Mok MY; Lau CS
Clin Rheumatol; 2008 Apr; 27(4):429-36. PubMed ID: 17899308
[TBL] [Abstract][Full Text] [Related]
18. The risk of nontuberculous mycobacterial infection in patients with Sjögren's syndrome: a nationwide, population-based cohort study.
Chao WC; Lin CH; Liao TL; Chen YM; Hsu CY; Chen JP; Chen DY; Chen HH
BMC Infect Dis; 2017 Dec; 17(1):796. PubMed ID: 29282007
[TBL] [Abstract][Full Text] [Related]
19. The therapy of Sjogren's syndrome: a review.
Coaccioli S; Giuliani M; Puxeddu A
Clin Ter; 2007; 158(5):453-6. PubMed ID: 18062353
[TBL] [Abstract][Full Text] [Related]
20. Increased risks of deep vein thrombosis and pulmonary embolism in Sjögren syndrome: a nationwide cohort study.
Chung WS; Lin CL; Sung FC; Hsu WH; Chen YF; Kao CH
J Rheumatol; 2014 May; 41(5):909-15. PubMed ID: 24692530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
